Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CARsgen Therapeutics Receives IND Clearance for BCMA-CAR-T Cells from the NMPA 2019-03-01 18:00
CStone Pharmaceuticals listed on the Hong Kong Stock Exchange today 2019-02-27 10:47
China Biologic Products to Report Fourth Quarter and Fiscal Year 2018 Financial Results 2019-02-25 21:00
Foresee Pharmaceuticals Announces Successful Topline Results from Phase 3 Registration Study of LMIS 25 mg in Prostate Cancer 2019-02-21 18:30
Mallinckrodt Announces Interim Analysis Results for Therakos® Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease 2019-02-21 16:00
Shanghai Concord Medical Cancer Center's Basic Medical Services have been Fully Covered by Medical Insurance 2019-02-20 17:41
ROKIT Healthcare Announces a Novel Application of Dermal Regeneration Platform Using Proprietary Three-Dimensional Bioprinting Strategy 2019-02-20 13:49
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2019 Financial Results 2019-02-19 19:00
Chipscreen Biosciences Announces a Collaboration with Innovent to Evaluate Chidamide and the Combination of Sintilimab, Anti-VEGF Monoclonal Antibody IBI305 in Colorectal Cancer patients 2019-02-18 10:08
Spring Pharmaceutical Group Inc. Reports Financial Results for the Three and Nine Months Ended December 31, 2018 2019-02-15 05:15
Burning Rock announces the completion of the Series C financing of RMB 850 million and strives to build an international leading tumor precision medicine brand 2019-02-14 14:33
Mayne Pharma launches Lexette (TM) (halobetasol propionate) foam 0.05% in the United States 2019-02-13 20:30
GC Pharma Reports Full Year 2018 Results 2019-02-12 22:00
Education Resources, Inc. to Offer Online Course "Vestibular Rehabilitation for the School-Aged Child and Adolescent" 2019-02-12 21:07
Bridge Biotherapeutics Presented Preclinical and Phase I Study Results for BBT-401 at the Crohn's & Colitis Congress 2019-02-11 22:00
3SBio and Verseau Establish Global Clinical Development Collaboration for First-in-class Immuno-Oncology Therapies 2019-02-11 20:18
Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare 2019-02-11 18:30
CStone and IMPACT Therapeutics' clinical collaboration progresses to IND filing acceptance for CS1001+IMP4297 combination therapy 2019-02-08 03:10
Taiho Pharmaceutical and Cullinan Oncology Establish Collaboration to Develop TAS6417, Novel EGFR Tyrosine Kinase Inhibitor 2019-02-05 16:00
GeneQuantum Healthcare and MITRO Biotech Enter into Strategic Cooperation to Develop Next Generation Radionuclide Conjugates 2019-02-03 20:00
1 198 199 200 201 202 402